
Ben Harmssen – Symposium Guest Speaker
Profiling Cancer for Precision Oncology: Biomarker Testing
…

Hereditary Breast Cancer Testing: New Recommendations
0 Comments
/
Earlier this year, the American Society of Breast Surgeons…

An update to tumor testing coverage for Medicare patients
Earlier this month, the Centers for Medicare and Medicaid…

Vitrakvi approved for NTRK+ cancers | MyOncoPath
FDA approves Vitrakvi in all tumor types with NTRK gene variants
Progress…

CNN Article: Breast cancer testing guidelines are out of date, missing genetic screening
Link to article: https://amp.cnn.com/cnn/2018/12/10/health/breast-cancer-genetic-testing-study
As…

FoundationOne CDx Comprehensive Genomic Profiling for Solid Tumors Now Commercially Available
Foundation Medicine Announces Commercial Availability of FoundationOne…

FDA approves first treatment for breast cancer with a certain inherited genetic mutation
The U.S. Food and Drug Administration today expanded the approved…
